Ratings by Roth/MKM (Yasmeen Rahimi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/23/2020 | Seelos Therapeutics | SEEL | New Coverage | Buy (N/A) |
1.51 (5.19) |
243.71% | Details | |
| 6/4/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | CymaBay Therapeutic | CBAY | Upgrade | Buy (Neutral) |
1.84 (32.48) |
1665.22% | Details | |
| 5/8/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2020 | Lumos Pharma | LUMO | New Coverage | Buy (N/A) |
9.31 (4.34) |
-53.38% | Details | |
| 4/15/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2020 | Stealth BioTherapeutics | MITO | New Coverage | Buy (N/A) |
1.59 (0.32) |
-79.87% | Details | |
| 3/25/2020 | Immunic Inc. | IMUX | New Coverage | Buy (N/A) |
5.74 (0.72) |
-87.46% | Details | |
| 2/24/2020 | Altimmune | ALT | New Coverage | Buy (N/A) |
1.76 (2.82) |
60.23% | Details | |
| 2/13/2020 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2020 | Millendo Therapeutics Inc. | MLND | New Coverage | Buy (N/A) |
7.63 (1.06) |
-86.11% | Details | |
| 12/23/2019 | Crinetics | CRNX | New Coverage | Buy (N/A) |
21.91 (36.70) |
67.5% | Details | |
| 12/16/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2019 | CymaBay Therapeutic | CBAy | Downgrade | Neutral (Buy) |
1.33 (1.84) |
38.35% | Details | |
| 11/7/2019 | Hepion Pharma | HEPA | New Coverage | Buy (N/A) |
2.95 (3.70) |
25.42% | Details | |
| 10/25/2019 | Moderna | MRNA | New Coverage | Buy (N/A) |
16.59 (67.27) |
305.49% | Details | |
| 9/6/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2019 | Zafgen | ZFGN | Downgrade | Neutral (Buy) |
0.70 (0.99) |
41.43% | Details | |
| 9/4/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2019 | LogicBio Therapeutics | LOGC | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2019 | Akero Therapeutics | AKRO | New Coverage | Buy (N/A) |
19.88 (54.74) |
175.35% | Details | |
| 7/2/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2019 | Acer Therapeutics | ACER | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | Amarin Corporation | AMRN | New Coverage | Buy (N/A) |
18.66 (15.91) |
-14.74% | Details | |
| 5/14/2019 | Seelos Therapeutics | SEEL | New Coverage | Buy (N/A) |
2.86 (1.28) |
-55.24% | Details | |
| 5/1/2019 | LogicBio Therapeutics | LOGC | New Coverage | Buy (N/A) |
15.00 (7.06) |
-52.93% | Details | |
| 4/26/2019 | Zafgen | ZFGn | New Coverage | Buy (N/A) |
2.38 (0.70) |
-70.59% | Details | |
| 3/26/2019 | Conatus Pharmaceuticals | CNAT | Downgrade | Neutral (Buy) |
1.28 (0.56) |
-56.25% | Details | |
| 3/21/2019 | The Medicines Company | MDCO | New Coverage | Buy (N/A) |
26.54 (84.90) |
219.89% | Details | |
| 2/19/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2018 | Eidos Therapeutics | EIDX | New Coverage | Buy (N/A) |
11.81 (122.21) |
934.8% | Details | |
| 9/12/2018 | Intercept Pharmaceuticals | ICPT | New Coverage | Buy (N/A) |
114.21 (19.00) |
-83.36% | Details |
